Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important

Am J Respir Crit Care Med. 2020 Nov 15;202(10):1482. doi: 10.1164/rccm.202004-1489LE.

Authors

Donald A Mahler^{1

2}, Jill A Ohar³, Gary T Ferguson⁴, James F Donohue⁵

Affiliations

¹ Geisel School of Medicine at Dartmouth Hanover, New Hampshire.
² Valley Regional Hospital Claremont, New Hampshire.
³ Wake Forest University School of Medicine Winston-Salem, North Carolina.
⁴ Pulmonary Research Institute of Southeast Michigan Farmington Hills, Michigan and.
⁵ University of North Carolina School of Medicine Chapel Hill, North Carolina.

No abstract available

Publication types

Letter
Comment

MeSH terms

Bronchodilator Agents / therapeutic use
Humans
Pulmonary Disease, Chronic Obstructive* / drug therapy
United States

Substances

Bronchodilator Agents